The characters shown are real patients and the required consent to use their stories has been obtained from the patients and families. Photographs are for illustrative purposes only.
Spinal muscular atrophy (SMA) is a rare genetic neuromuscular disease caused by a mutation in the survival motor neuron 1 (SMN1) gene.1
SMA is divided into different types according to the age of onset and functional ability. There is also a range of severity within each type.2
SMA is an inherited disease and unlike many other rare neuromuscular diseases, there is a clear understanding of the specific genetic cause of spinal muscular atrophy.3
Although SMA is characterised by certain signs and symptoms, there are other conditions presenting with similar symptoms but with different genetic causes.
When SMA is suspected it is important to have the initial diagnosis be confirmed through genetic testing.4
At Biogen, we are committed to supporting those with spinal muscular atrophy and their care team. Our hope for Together in SMA is that, by providing information, we can help you to get the most up-to-date care, and to help guide conversations with your doctors.
Spinal muscular atrophy (SMA) is a rare genetic neuromuscular disease caused by a mutation in the survival motor neuron 1 (SMN1) gene1
SMA is divided into different types according to the age of onset and functional ability. There is also a range of severity within each type.2
SMA is an inherited disease and unlike many other rare neuromuscular diseases, there is a clear understanding of the specific genetic cause of spinal muscular atrophy.3
When SMA is suspected it is important to have the initial diagnosis be confirmed through genetic testing.4
At Biogen, we are committed to supporting those with spinal muscular atrophy and their care team. Our hope for Together in SMA is that, by providing information, we can help you to get the most up-to-date care, and to help guide conversations with your doctors.
At Biogen, we are committed to supporting those with spinal muscular atrophy and their care team. Our hope for Together in SMA is that, by providing information, we can help you to get the most up-to-date care, and to help guide conversations with your doctors.
The characters shown are real patients and the required consent to use their stories has been obtained from the patients and families.
Photographs are for illustrative purposes only.
“The diagnostic process for SMA has not changed since the original consensus statement paper… unless there are previous familial cases, the diagnostic process is generally prompted by the clinical signs.”4
1. Lunn MR, Wang CH. Spinal muscular atrophy. Lancet. 2008;371(9630):2120-2133.
2. Kolb SJ, Kissel JT. Spinal muscular atrophy. Arch Neurol. 2011;68(8):979-984.
3. National Organization for Rare Disorders. Spinal Muscular Atrophy. [online] 2012 [cited 2020 Sep 22].
Available from: URL: https://rarediseases.org/rare-diseases/spinal-muscular-atrophy/.
4. EGL Genetics. Congenital Hypotonia Panel: Spinal Muscular Atrophy Deletions, Prader-Willi/Angelman Syndrome Methylation, Myotonic Dystrophy, and Uniparental Disomy 14. Available at: http://geneticslab.emory.edu/tests/HY. Accessed January 9, 2017.
5. Mercuri E, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord 2018;28(2):103-115.